Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Navidea Biopharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 2 | 1 | −1 |
| Shares | 105 | 100 | −5 (−4.8%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (1)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Runnymede Capital Advisors, Inc. | 5 | $0 |